Toddle ran over by van in china
Truly shocking and disturbing… Warning strong images… BEIJING – More than a dozen passers-by ignored a two-year-old girl as she lay critically injured on a street in southern China after being run over twice, the official Xinhua news agency said Monday. The incident has sparked outrage on China’s hugely popular social More...
J&J’s prostate cancer drug approved in EU
LONDON (Reuters) – Johnson & Johnson’s prostate cancer drug Zytiga has been approved in the European Union, paving the way for the launch of a new treatment for men whose disease has progressed More...
Plant-rich diets tied to lower breast cancer risk
NEW YORK (Reuters Health) – Women with diets rich in vegetables, fruit and legumes may have a somewhat decreased risk of developing one type of breast cancer, a new study suggests. Link: Plant-rich diets More...
UK watchdog changes mind to back bone cancer drug
LONDON(Reuters) – Britain’s health costs watchdog NICE has decided to back Japanese drugmaker Takeda’s bone cancer drug Mepact after re-assessing the impact of a discount on the medicine for patients More...
Cholera deaths in Chad ‘could double’: Red Cross
The Red Cross on Wednesday warned that without a response the number of people in Chad infected with cholera could double to 25,000 people from the 12,713 cases recorded so far this year. View the original here: Cholera More...
"Sleep debt" tied to attention trouble in teens
NEW YORK (Reuters Health) – High school students who catch up on sleep over the weekend do worse on attention tests in school than kids who don’t get extra shuteye, according to a new study from South More...
Chinese vitamin C makers lose antitrust ruling
NEW YORK (Reuters) – In a long-running case that has tested the limits of antitrust law, four Chinese companies accused of fixing vitamin C prices have been stripped of a key defense. More: Chinese vitamin More...
Hospital ratings for kids a roll of the dice: study
NEW YORK (Reuters Health) – A key component of children’s hospital ratings may be statistically unreliable, fueling concerns over popular rankings used by millions of Americans every year, according More...
Vertex rheumatoid arthritis drug meets study goals
NEW YORK (Reuters) – Vertex Pharmaceuticals Inc said its experimental oral drug for rheumatoid arthritis met the main goals of a mid-stage study. View original post here: Vertex rheumatoid arthritis drug meets More...
Bayer, J&J stroke drug not ready for approval: FDA
WASHINGTON (Reuters) – Drug regulators said an experimental stroke preventer from Bayer and Johnson & Johnson is not ready for approval and raised questions about its effectiveness, sending Bayer shares More...
